Massimo Antonelli, MD

Head
Università Cattolica del Sacro Cuore, Italy

Disclosure(s): Fisher & Paykel Healthcare: Grant/Research Support; GE Healthcare: Grant/Research Support; Menarini: Advisor/Consultant; Pfizer: Advisor/Consultant; Shionogi BV: Advisor/Consultant

Poster(s):

• (P-1352) Clinical Outcomes of Cefiderocol for Treatment of Bloodstream Infections Caused by Gram-Negative Bacteria: Subgroup Analysis of the PROVE Study
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET